Feb 4, 2020 | Delivery difficulties
The FDA has issued a statement to encourage the development of complex generics to provide access to patients and promote healthy competition. Efforts to advance the development of complex generic...
Dec 31, 2019 | Delivery difficulties
No delivery problems on our part
Aug 14, 2017 | Delivery difficulties
In the course of risk management, it is worthwhile to register two active ingredient manufacturers with your own authority for drug approval. It is often sufficient to produce laboratory batches instead of validation batches for the registration of the second source....
